| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIRE
|
autoimmune regulator
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
AR
|
androgen receptor
|
|
ATM
|
ATM serine/threonine kinase
|
|
B2M
|
beta-2-microglobulin
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL7A
|
B-cell CLL/lymphoma 7A
|
|
BCL9
|
B-cell CLL/lymphoma 9
|
|
BCR
|
breakpoint cluster region
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
CARD10
|
caspase recruitment domain family, member 10
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCND2
|
cyclin D2
|
|
CCNT1
|
cyclin T1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD34
|
CD34 molecule
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD5
|
CD5 molecule
|
|
CD68
|
CD68 molecule
|
|
CD69
|
CD69 molecule
|
|
CD8A
|
CD8a molecule
|
|
CD99
|
CD99 molecule
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CHD4
|
chromodomain helicase DNA binding protein 4
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLU
|
clusterin
|
|
CNN3
|
calponin 3, acidic
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTRL
|
centriolin
|
|
CORT
|
cortistatin
|
|
CR1L
|
complement component (3b/4b) receptor 1-like
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CYP4F3
|
cytochrome P450, family 4, subfamily F, polypeptide 3
|
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
ECE1
|
endothelin converting enzyme 1
|
|
ECE2
|
endothelin converting enzyme 2
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMNL1
|
formin-like 1
|
|
FOXP1
|
forkhead box P1
|
|
G3BP1
|
GTPase activating protein (SH3 domain) binding protein 1
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GH1
|
growth hormone 1
|
|
GPR132
|
G protein-coupled receptor 132
|
|
GRAP2
|
GRB2-related adaptor protein 2
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC6
|
histone deacetylase 6
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HOXB4
|
homeobox B4
|
|
HPSE
|
heparanase
|
|
HRH4
|
histamine receptor H4
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IGH
|
immunoglobulin heavy locus
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL16
|
interleukin 16
|
|
IL1A
|
interleukin 1, alpha
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL25
|
interleukin 25
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL33
|
interleukin 33
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IL9
|
interleukin 9
|
|
IL9R
|
interleukin 9 receptor
|
|
IRF4
|
interferon regulatory factor 4
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
KDM4C
|
lysine (K)-specific demethylase 4C
|
|
KDR
|
kinase insert domain receptor
|
|
KISS1R
|
KISS1 receptor
|
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LDHA
|
lactate dehydrogenase A
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LTA
|
lymphotoxin alpha
|
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
|
MADCAM1
|
mucosal vascular addressin cell adhesion molecule 1
|
|
MALT1
|
MALT1 paracaspase
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MCM3AP
|
minichromosome maintenance complex component 3 associated protein
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR199B
|
microRNA 199b
|
|
MIR221
|
microRNA 221
|
|
MIR223
|
microRNA 223
|
|
MIR23A
|
microRNA 23a
|
|
MIR27A
|
microRNA 27a
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOTCH1
|
notch 1
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRP1
|
neuropilin 1
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PAX5
|
paired box 5
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PDCD1
|
programmed cell death 1
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PF4
|
platelet factor 4
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM16
|
PR domain containing 16
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROM1
|
prominin 1
|
|
PSEN2
|
presenilin 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PXN
|
paxillin
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELT
|
RELT tumor necrosis factor receptor
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SGMS1
|
sphingomyelin synthase 1
|
|
SH2D2A
|
SH2 domain containing 2A
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SMAD4
|
SMAD family member 4
|
|
SMPD2
|
sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase)
|
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TBX21
|
T-box 21
|
|
TCF3
|
transcription factor 3
|
|
TENM2
|
teneurin transmembrane protein 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBS1
|
thrombospondin 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TK2
|
thymidine kinase 2, mitochondrial
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TOB2
|
transducer of ERBB2, 2
|
|
TP53
|
tumor protein p53
|
|
TPT1
|
tumor protein, translationally-controlled 1
|
|
TRD
|
T cell receptor delta locus
|
|
TRIM8
|
tripartite motif containing 8
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
VSTM1
|
V-set and transmembrane domain containing 1
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
ZNRD1
|
zinc ribbon domain containing 1
|
